Press Release
A new class of therapies to treat cardiovascular diseasesMicroRNA researchers win the Nobel Prize
The Nobel Prize in Physiology or Medicine 2024 has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on microRNA. Their discoveries help explain how complex life emerged on Earth and how the human body is made up of a wide variety of different...
read moreJaan Biotherapeutics Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network
San Diego, California Sep 9, 2024 (Issuewire.com) - Jaan Biotherapeutics, a company developing microRNA targeting treatments for heart disease, the leading cause of death of both women and men in the United States of America, announced today that it was selected as a...
read moreNIH Small Business Grants
JaanBiotherapeutics has been awarded the following NIH funded small business grants.
read moreGlobal Ischemic Heart Disease Pipeline, 2020 and Beyond
Ischemic Heart Disease is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s potential. Development of Ischemic Heart Disease medicines is identified as integral to the strategy of the majority of companies operating in the industry.
read moreOur 2019 Quick Pitch Top Ten Finalists
CONGRATULATIONS TO ALL THE 2019 QUICK PITCH WINNERS! Opening with a rousing rendition of Eminem’s “Lose Yourself” by The School of Rap, and alumni company update from Trust & Will, the 12th Anniversary Quick Pitch broke records for applications, attendance and...
read moreJAAN BIOTHERAPEUTICS INC. ANNOUNCES NIH GRANT AWARD
JaanBio announces that a National Institute of Health grant of $225,000 has been awarded to Jaan Bio under the NIH Small Business Innovative Research program.
read more